Kidney Transplant Failure and Rejection

Nephrology
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Roche
RocheSTAVANGER NORWAY, Norway
1 program
1
TacrolimusPhase 41 trial
Active Trials
NCT00166712Terminated40Est. Apr 2010
Hansa Biopharma
Hansa BiopharmaSweden - Lund
1 program
ImlifidaseN/A1 trial
Active Trials
NCT03611621CompletedEst. Feb 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
RocheTacrolimus
Hansa BiopharmaImlifidase

Clinical Trials (2)

Total enrollment: 40 patients across 2 trials

A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression

Start: Apr 2005Est. completion: Apr 201040 patients
Phase 4Terminated

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Start: Jun 2018Est. completion: Feb 2023
N/ACompleted

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space